Market Place
Sourcing Support
Tenaya Therapeutics Reports Q4 & FY25 Results, Business Update
11 Mar 2026 //
GLOBENEWSWIRE
Tenaya, Alnylam Ink Collab to Find Gene Targets For Cardio Drugs
05 Mar 2026 //
FIERCE BIOTECH
Tenaya Therapeutics at Leerink Global Healthcare Conference
02 Mar 2026 //
GLOBENEWSWIRE
Tenaya Pharma Reveals 2026 Goals And Key Milestones
09 Jan 2026 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Pricing Of Public Offering
12 Dec 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Reveals Positive Interim Results
11 Dec 2025 //
GLOBENEWSWIRE
Tenaya Resolves Clinical Hold On Mypeak-1 Gene Therapy Trial
11 Dec 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Proposed Public Offering
11 Dec 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q3 2025 Financials & Business Update
10 Nov 2025 //
GLOBENEWSWIRE
FDA Puts Tenaya Heart Disease Gene Therapy Trial On Hold
10 Nov 2025 //
FIERCE BIOTECH
Tenaya Therapeutics Present Positive Interim Data From TN-201
08 Nov 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics To Present New TN-201 Gene Therapy Data
04 Nov 2025 //
GLOBENEWSWIRE
Tenaya Participate H.C. Wainwright Genetic Medicines Conference
09 Oct 2025 //
GLOBENEWSWIRE
Tenaya to Participate in Upcoming October Investor Conferences
02 Oct 2025 //
GLOBENEWSWIRE
Tenaya Reports Inducement Grants under Nasdaq LR 5635(c)(4)
18 Sep 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics to Present at Morgan Stanley Confernece
02 Sep 2025 //
GLOBENEWSWIRE
Tenaya Reports Data From MyClimb HCM Study at ESC Congress 2025
31 Aug 2025 //
GLOBENEWSWIRE
Tenaya Joins Canaccord Genuity 45th Annual Growth Conference
08 Aug 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q2 2025 Financials and Updates
06 Aug 2025 //
GLOBENEWSWIRE
Tenaya Gene Therapy Trials Advance After DSMB Review
30 Jul 2025 //
GLOBENEWSWIRE
Tenaya Reports Inducement Grants under Nasdaq LR 5635(c)(4)
15 May 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics to Showcase Research at ASGCT Meeting
13 May 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q1 2025 Results and Business Update
07 May 2025 //
GLOBENEWSWIRE
Tenaya Cuts Workforce to Fund Cardio Gene Therapies
01 Apr 2025 //
BIOSPACE
Tenaya Therapeutic presents data from MyPEAK-1 trial at ACC Meeting
31 Mar 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics: TN-201 Improve Cardiac Function in MYBPC3 Model
24 Mar 2025 //
GLOBENEWSWIRE
Tenaya To Present Late Breaker & Data At ACC 2025
19 Mar 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q4 and Full Year 2024 Results
10 Mar 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Proposed Public Offering
03 Mar 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Pricing of Public Offering
03 Mar 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces 2025 Priorities & Milestones
13 Jan 2025 //
GLOBENEWSWIRE
Tenaya Reports Early Data from MyPEAK™-1 Trial for Cardiomyopathy
17 Dec 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces MyPEAK-1 Data on TN-201
16 Dec 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Doses First Patient in TN-401 Phase 1b Trial
25 Nov 2024 //
GLOBENEWSWIRE
Tenaya Reports Inducement Grants Under NASDAQ Rule 5635(c)(4)
19 Nov 2024 //
GLOBENEWSWIRE
Tenaya Updates On TN-201 Gene Therapy For HCM
17 Oct 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Tenaya: Gene Editing, Manufacturing Capabilities At ASGCT Meeting
02 May 2024 //
GLOBENEWSWIRE
Tenaya Announces Publication of TN-401 Gene Therapy Preclinical Data
18 Mar 2024 //
GLOBENEWSWIRE
Tenaya Announces Publication of TN-401 Gene Therapy Preclinical Data
18 Mar 2024 //
GLOBENEWSWIRE
Tenaya`s cardiac gene therapy boosts long-term survival in mice
18 Mar 2024 //
FIERCE BIOTECH
Tenaya Therapeutics Doses First Patient in the MyPeak-1 Phase 1b Trial of TN-201
05 Oct 2023 //
GLOBENEWSWIRE
